SEC Form 4 · accession 0001179110-16-019924
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas C Freyman
Officer — Executive Vice President
Period of report
Feb 19, 2016
Accepted (ET)
Feb 23, 2016 · 6:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par valueF1 | Feb 19, 2016 | A | 55,338 | $0.00 | A | 402,590 | D | |
| Common shares without par valueF2 | holding | — | — | — | 1,123 | I | Profit Sharing Trust | |
| Common shares without par valueF3 | holding | — | — | — | 4,000 | I | Annette Newton-Freyman 1994 Trust | |
| Common shares without par valueF4 | holding | — | — | — | 76,000 | I | Annette Newton-Freyman 2012 Irrevocable Trust | |
| Common shares without par valueF5 | holding | — | — | — | 76,000 | I | Thomas C. Freyman 2012 Irrevocable Trust | |
| Common shares without par valueF6 | holding | — | — | — | 1,941 | I | By spouse as trustee for son | |
| Common shares without par valueF6 | holding | — | — | — | 1,941 | I | By spouse as trustee for son |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F7 | $38.40 | Feb 19, 2016 | A | 485,159 | A | Feb 19, 2017 | Feb 18, 2026 | Common shares | 485,159 | 485,159 | D |
Explanation of responses
- F1These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- F2Balance in the Abbott Laboratories Stock Retirement Trust as of February 19, 2016.
- F3Held in the Annette Newton-Freyman 1994 Trust. The reporting person's spouse is trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.
- F4Held in the Annette Newton-Freyman 2012 Irrevocable Trust. The reporting person is trustee of the trust. The trust is irrevocable. The reporting person disclaims beneficial ownership of these securities.
- F5Held in the Thomas C. Freyman 2012 Irrevocable Trust. The reporting person's spouse is trustee of the trust. The trust is irrevocable.
- F6The reporting person disclaims beneficial ownership of all securities held by his son.
- F7Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 161,720 on 02/19/2017, 161,719 on 02/19/2018, and 161,720 on 02/19/2019.